StonvexLoading…
StonvexStonvexStonvexCore line items from CEVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $109.60M | $106.94M | $97.42M | $120.58M |
Operating Income | $-11.35M | $-7.54M | $-13.47M | $3.90M |
Net Income | $-10.64M | $-8.79M | $-11.88M | $-23.18M |
EPS (Diluted) | $-0.44 | $-0.37 | $-0.51 | $-1.00 |
Total Assets | $388.26M | $308.95M | $304.08M | $308.44M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $40.59M | $18.50M | $23.29M | $20.12M |
Free Cash Flow OCF − CapEx | $-6.28M | $516.00K | $-9.21M | $3.42M |
Shares Outstanding | 27.51M | 23.63M | 23.44M | 23.22M |